Crossmark

Preclinical exploration of combining plasmacytoid and myeloid dendritic cell vaccination with BRAF inhibition

Crossref DOI link: https://doi.org/10.1186/s12967-016-0844-6

Published Online: 2016-04-14

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tel, Jurjen

Koornstra, Rutger

de Haas, Nienke

van Deutekom, Vincent

Westdorp, Harm

Boudewijns, Steve

van Erp, Nielka

Di Blasio, Stefania

Gerritsen, Winald

Figdor, Carl G.

de Vries, I. Jolanda M.

Hato, Stanleyson V.
Funding

Funding for this research was provided by:

KWF Kankerbestrijding (KUN2009-4402, KUN2013-5958)

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (863.13.024, 918.14.655)

European Research Council (269019)